|
TM2D1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.537659999995E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.030200E-04 |
| Normal-vs-Stage2 |
1.011830E-01 |
| Normal-vs-Stage3 |
1.72801999999139E-05 |
| Normal-vs-Stage4 |
1.11960000048761E-07 |
| Stage1-vs-Stage2 |
4.009200E-01 |
| Stage1-vs-Stage3 |
4.022200E-02 |
| Stage1-vs-Stage4 |
3.215800E-03 |
| Stage2-vs-Stage3 |
3.887500E-02 |
| Stage2-vs-Stage4 |
1.190480E-02 |
| Stage3-vs-Stage4 |
4.642400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.03599999999415E-05 |
| Normal-vs-AfricanAmerican |
1.009380E-04 |
| Normal-vs-Asian |
1.366600E-01 |
| Caucasian-vs-AfricanAmerican |
4.263600E-01 |
| Caucasian-vs-Asian |
9.789800E-01 |
| AfricanAmerican-vs-Asian |
7.087200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8534000000292E-06 |
| Normal-vs-Female |
8.610600E-04 |
| Male-vs-Female |
8.783900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.261000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.77550000000282E-05 |
| Normal-vs-Age(61-80Yrs) |
7.76260000000528E-05 |
| Normal-vs-Age(81-100Yrs) |
3.198300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.594600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.340800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.240800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.481200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.939600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.529800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.275600E-01 |
| Normal-vs-Grade 2 |
2.468000E-02 |
| Normal-vs-Grade 3 |
1.02080000008442E-09 |
| Normal-vs-Grade 4 |
1.83770000328209E-08 |
| Grade 1-vs-Grade 2 |
4.453000E-01 |
| Grade 1-vs-Grade 3 |
5.659200E-03 |
| Grade 1-vs-Grade 4 |
2.817400E-03 |
| Grade 2-vs-Grade 3 |
1.38069999999768E-06 |
| Grade 2-vs-Grade 4 |
1.99760999999299E-05 |
| Grade 3-vs-Grade 4 |
1.915750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.159900E-02 |
| Normal-vs-ccB subtype |
4.18750000008572E-07 |
| ccA subtype-vs-ccB subtype |
2.70599999996346E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.355800E-04 |
| Normal-vs-N1 |
6.282200E-03 |
| N0-vs-N1 |
3.406600E-01 |
|
|
